Advertisement
Screener

Biostar Pharmaceuticals, Inc. Accumulated Other Comprehensive Income

Biostar Pharmaceuticals, Inc. Accumulated Other Comprehensive Income

Biostar Pharmaceuticals, Inc. had Accumulated Other Comprehensive Income of $2.40 million as of 2017-09-30, per its 10-Q filed 2017-11-20.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2017-11-20

  • 2017-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.40M.
  • 2017-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.62M.
  • 2017-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $997.56K.
  • 2016-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $680.65K.
Period endAccumulated Other Comprehensive Income (Loss), Net of Tax
2017-09-30$2.40M
10-Q · filed 2017-11-20
2017-06-30$1.62M
10-Q · filed 2017-11-15
2017-03-31$997.56K
10-Q · filed 2017-05-19
2016-12-31$680.65K
10-Q · filed 2017-11-20
2016-09-30$2.28M
10-Q · filed 2016-11-21
2016-06-30$2.46M
10-Q · filed 2016-08-22
2016-03-31$3.74M
10-Q · filed 2016-05-23
2015-12-31$3.43M
10-Q · filed 2017-11-20
2015-09-30$3.91M
10-Q · filed 2015-11-23
2015-06-30$7.05M
10-Q · filed 2015-08-19
2015-03-31$6.77M
10-Q · filed 2015-05-15
2014-12-31$6.39M
10-K · filed 2017-04-13
2014-09-30$6.22M
10-Q · filed 2014-11-14
2014-06-30$6.17M
10-Q · filed 2014-08-14
2014-03-31$6.07M
10-Q · filed 2014-05-15
2013-12-31$6.60M
10-K · filed 2016-04-14
2013-09-30$6.30M
10-Q · filed 2013-11-14
2013-06-30$5.91M
10-Q · filed 2013-08-19
2013-03-31$4.97M
10-Q · filed 2013-05-15
2012-12-31$4.53M
10-K · filed 2015-04-15
2012-09-30$4.16M
10-Q · filed 2012-11-19
2012-06-30$4.28M
10-Q · filed 2012-08-14
2012-03-31$4.24M
10-Q · filed 2012-05-15
2011-12-31$3.98M
10-K · filed 2014-03-31
2011-09-30$3.71M
10-Q · filed 2011-11-14
2011-06-30$3.07M
10-Q · filed 2011-08-15
2010-12-31$1.98M
10-K · filed 2013-04-15